Presented here is a protocol to deliver oligonucleotides such as small-interfering RNA (siRNA), micro-RNA mimics (miRs), or anti-micro-RNA (anti-miR) into mature adipocytes to modulate protein and micro-RNA expression.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Presented here is a protocol to deliver oligonucleotides such as small-interfering RNA (siRNA), micro-RNA mimics (miRs), or anti-micro-RNA (anti-miR) into mature adipocytes to modulate protein and micro-RNA expression.
Alteration of adipocyte function contributes to the pathogenesis of metabolic diseases including Type 2 diabetes and insulin resistance. This highlights the need to better understand the molecular mechanism involved in adipocyte dysfunction to develop new therapies against obesity-related diseases. Modulating the expression of proteins and micro-RNAs in adipocytes remains highly challenging. This paper describes a protocol to differentiate murine fibroblasts into mature adipocytes and to modulate the expression of proteins and micro-RNAs in mature adipocytes through reverse-transfection using small-interfering RNA (siRNA) and micro-RNA mimicking (miR mimic) oligonucleotides. This reverse-transfection protocol involves the incubation of the transfection reagent and the oligonucleotides to form a complex in the cell culture plate to which the mature adipocytes are added. The adipocytes are then allowed to reattach to the adherent plate surface in the presence of the oligonucleotides/transfection reagent complex. Functional analyses such as the study of insulin signaling, glucose uptake, lipogenesis, and lipolysis can be performed on the transfected 3T3-L1 mature adipocytes to study the impact of protein or micro-RNA manipulation on adipocyte function.
Obesity is considered a major risk factor for numerous metabolic diseases, including insulin resistance (IR), Type 2 Diabetes (T2D), and cardiovascular diseases1. Current therapies have failed to stop the constantly rising prevalence of these diseases, and the management of the IR of obese and diabetic patients remains an important clinical issue. Adipose tissue plays a crucial role in the control of energy homeostasis, and its pathological expansion during obesity contributes to the development of IR and T2D2,3. This highlights the need to better understand the molecular mechanism invo....
Access restricted. Please log in or start a trial to view this content.
NOTE: Use sterile techniques to perform all the steps of the protocol in a laminar flow cell culture hood. See Table of Materials for details about all reagents and equipment.
1. Differentiation of murine 3T3-L1 fibroblasts into adipocytes
Access restricted. Please log in or start a trial to view this content.
Using the procedure of reverse-transfection described here to modulate the expression of proteins or micro-RNAs in 3T3-L1 adipocytes, the adipocytes have been shown to preserve their morphology after the transfection (Figure 1B,C). Indeed, 2 days after the transfection, the adipocytes were well-spread and attached to the plate and presented multilocular lipid droplets that are a characteristic of mature 3T3-L1 adipocytes. The lipid content wa.......
Access restricted. Please log in or start a trial to view this content.
This paper presents a detailed protocol for the differentiation and transfection of mature adipocytes. This reverse-transfection method is a simple, economical, and highly efficient method to transfect oligonucleotides such as, but not limited to, siRNAs, micro-RNA mimics, and anti-micro-RNAs into 3T3-L1 adipocytes, which is one of the most difficult cell lines to transfect. This method has some limitations that need to be considered. This protocol is not efficient for transfection with plasmid DNA, which limits the util.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This work was supported by INSERM, the Université Côte d'Azur, and the French National Research Agency (ANR) through the program Investments for the future Laboratory of Excellence (Labex SIGNALIFE-ANR-11-LABX-0028-01) and Initiative of Excellence (Idex UCAJEDI ANR-15-IDEX-0001). J.J. is supported by grants from the Société Francophone du Diabète (SFD), the Association Française d'Etude et de Recherche sur l'Obésité (AFERO), the Institut Thématique Multi-Organismes Technologies pour la Santé (ITMO), and the Fondation Benjamin-Delessert. J.G. is supported by ANR-18-CE14-0035-01. J-F.T. is supported by ANR gr....
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 12 well Tissue Culture Plate | Dutscher | 353043 | |
| 2.5% Trypsin (10x) | Gibco | 15090-046 | diluted to 5x with D-PBS |
| 2-Propanol | Sigma | I9516 | |
| 3-Isobutyl-1-methylxanthine | Sigma-Aldrich | D5879 | |
| Accell Non-targeting Pool | Horizon Discovery | D-001910-10-05 | |
| Bovine Serum Albumin (BSA) | Sigma | A7030 | |
| Collagen type I from calf skin | Sigma-Aldrich | C8919 | |
| Dexamethasone | Sigma-Aldrich | D1756 | |
| D-PBS | Gibco | 14190144 | |
| Dulbecco's Modified Eagles's Medium (DMEM) | Gibco | 41965062 | 4.5 g/L D-Glucose; L-Glutamine; no Pyruvate |
| Ethanol | Sigma | 51976 | |
| FAM-labeled Negative Control si-RNA | Invitrogen | AM4620 | |
| Fetal Bovine Serum | Gibco | 10270-106 | |
| Free Glycerol Reagent | Sigma-Aldrich | F6428 | |
| Glycerol Standard Solution | Sigma-Aldrich | G7793 | |
| HSP90 antibody | Santa Cruz | sc-131119 | Dilution : 0.5 µg/mL |
| Improved Minimal Essential Medium (Opti-MEM) | Gibco | 31985-047 | |
| Insulin, Human Recombinant | Gibco | 12585-014 | |
| miRIDIAN micro-RNA mimics | Horizon Discovery | ||
| miRNeasy Mini Kit | Qiagen | 217004 | |
| miScript II RT Kit | Qiagen | 218161 | |
| miScript Primer Assays Hs_RNU6-2_11 | Qiagen | MS00033740 | |
| miScript Primer Assays Mm_miR-34a_1 | Qiagen | MS00001428 | |
| miScript SYBR Green PCR Kit | Qiagen | 219073 | |
| Newborn Calf Serum | Gibco | 16010-159 | |
| Oil Red O | Sigma | O0625 | |
| ON-TARGETplus Mouse Plin1 si-RNA SMARTpool | Horizon Discovery | L-056623-01-0005 | |
| Penicillin and Streptomycin | Gibco | 15140-122 | |
| Perilipin-1 antibody | Cell Signaling | 3470 | Dilution : 1/1000 |
| Petri dish 100 mm x 20 mm | Dutscher | 353003 | |
| PKB antibody | Cell Signaling | 9272 | Dilution : 1/1000 |
| PKB Phospho Thr308 antibody | Cell Signaling | 9275 | Dilution : 1/1000 |
| Rosiglitazone | Sigma-Aldrich | R2408 | |
| Transfection reagent (INTERFERin) | Polyplus | 409-10 | |
| α-tubulin antibody | Sigma aldrich | T6199 | Dilution : 0.5 µg/mL |
| Vamp2 antibody | R&D Systems | MAB5136 | Dilution : 0.1 µg/mL |
Access restricted. Please log in or start a trial to view this content.